Literature DB >> 21070989

Surgical management of stage III thymic tumors.

Federico Venuta1, Erino A Rendina, Walter Klepetko, Gaetano Rocco.   

Abstract

Thymic tumors are classified as stage III when they clearly invade the surrounding structures: pericardium, great vessels (superior vena cava, innominate veins, ascending aorta, and main pulmonary artery), lung parenchyma, phrenic nerves, and chest wall. Surgical treatment with or without induction therapy should always aim to complete resection removing en bloc all the involved structures. Also, extended procedures are justified because only R0 resection allows long-term survival.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21070989     DOI: 10.1016/j.thorsurg.2010.08.006

Source DB:  PubMed          Journal:  Thorac Surg Clin            Impact factor:   1.750


  4 in total

Review 1.  Surgical management of thymic epithelial tumors.

Authors:  Yasushi Shintani; Soichiro Funaki; Naoko Ose; Takashi Kanou; Eriko Fukui; Kenji Kimura; Masato Minami
Journal:  Surg Today       Date:  2020-07-10       Impact factor: 2.549

2.  Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database.

Authors:  Enrico Ruffini; Frank Detterbeck; Dirk Van Raemdonck; Gaetano Rocco; Pascal Thomas; Walter Weder; Alessandro Brunelli; Andrea Evangelista; Federico Venuta
Journal:  Eur J Cardiothorac Surg       Date:  2014-01-30       Impact factor: 4.191

3.  Is a diagnostic video-assisted thoracoscopic thymectomy an acceptable first-line approach to the suspicious anterior mediastinal mass?

Authors:  Ricky Vaja; Vijay Joshi; Alan G Dawson; David A Waller
Journal:  J Minim Access Surg       Date:  2017 Oct-Dec       Impact factor: 1.407

4.  Robotic thoracic surgery for resection of thymoma and tumors of the thymus: technical development and initial experience.

Authors:  Ricardo Mingarini Terra; José Ribas Milanez-de-Campos; Rui Haddad; Juliana Rocha Mol Trindade; Leticia Leone Lauricella; Benoit Jacques Bibas; Paulo Manuel Pêgo-Fernandes
Journal:  J Bras Pneumol       Date:  2019-12-13       Impact factor: 2.624

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.